| Annette F. Favorite |
Annette F. Favorite is currently the Chief Human Resources Officer & Senior VP at West Pharmaceutical Services, Inc. She is also a member of the Chester County Economic Development Council, The Forum of Executive Women, and the President of the Herman O West Foundation. Previously, she worked as the Vice President-Global Talent Management at International Business Machines Corp. Ms. Favorite received her undergraduate degree from the University of Georgia and her graduate degree from the University of South Carolina. |
| Bernard J. Birkett |
Bernard J. Birkett is currently the Senior VP, Chief Operations & Financial Officer at West Pharmaceutical Services, Inc. Prior to his current position, he served as the Chief Financial Officer & Treasurer at Merit Medical Systems, Inc. from 2016 to 2018. Mr. Birkett obtained a graduate degree from University College Dublin and UCD Michael Smurfit Graduate School of Business. He also holds an undergraduate degree from the National University of Ireland. |
| Chad R. Winters |
Chad R. Winters is currently the Chief Accounting Officer, VP & Controller at West Pharmaceutical Services, Inc. He previously worked as the Director at La Causa, Inc. and as the Controller, Senior VP-Finance & Accounting at Amneal Intermediate, Inc. Mr. Winters completed his undergraduate degree at Villanova University. |
| Cindy Reiss-Clark |
Cindy Reiss-Clark is currently the Chief Commercial Officer & Senior Vice President at West Pharmaceutical Services, Inc. She completed her undergraduate degree at the University of Kansas. |
| Kathy dePadua |
Kathy dePadua is currently the Chief Quality Officer & Vice President at West Pharmaceutical Services, Inc. She previously worked as the Group Vice President-Quality & Regulatory Affairs at Philips Electronics North America Corp. Ms. dePadua completed her undergraduate degree at Auburn University and holds an MBA from the University of Phoenix. |
| Silji Abraham |
Silji Abraham's current job is as the Chief Technology Officer & Senior Vice President at West Pharmaceutical Services, Inc. Mr. Abraham's former jobs include being the Chief Information Officer & EVP at EMD Millipore Corp. from 2015 to 2017, and the Chief Information Officer & Vice President at Sigma-Aldrich Corp. from 2012 to 2015. Mr. Abraham's education includes an MBA from Lawrence Technological University and an undergraduate degree from Madurai Kamaraj University. |
| Eric Mark Green |
Eric Mark Green is currently the Chairman, President & Chief Executive Officer at West Pharmaceutical Services, Inc. He is also an Independent Director at Ecolab, Inc. In addition, he holds positions as a Director at World Trade Center St. Louis, a Trustee at Bethel University, and a Trustee at St. Louis Children's Hospital. Previously, he served as the President-Research Business Unit & Executive VP at Sigma-Aldrich Corp. from 1993 to 2015. Mr. Green completed his undergraduate degree at Bethel University and earned an MBA from Olin Business School. |
| Douglas A. Michels |
Douglas A. Michels is an Independent Director at West Pharmaceutical Services, Inc. and a Trustee at St. Luke's Hospital & Health Network, Inc. He was previously the President, Chief Executive Officer & Director at OraSure Technologies, Inc. and the Group Vice President-Global Marketing at Ortho-Clinical Diagnostics, Inc. He also served as the President at Johnson & Johnson Health Care Systems, Inc. and as a Regional Manager-Sales at Ortho Diagnostic Systems, Inc. Additionally, he has served as a Director at the National Blood Foundation, The National Committee for Quality Health Care, Coalition to Protect America's Healthcare, and Miller Keystone Blood Center. Michels holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from the University of Illinois. |
| Paolo Pucci |
Paolo Pucci is currently the Lead Independent Director at West Pharmaceutical Services, Inc. He also holds positions as an Independent Non-Executive Director at Merus NV, an Independent Director at Replimune Group, Inc., and an Independent Director at Tarus Therapeutics, Inc. Previously, Mr. Pucci served as the Chief Executive Officer & Director at ArQule, Inc. from 2008 to 2020. He was also an Independent Director at Dyax Corp. from 2011 to 2016, and an Independent Director at NewLink Genetics Corp. from 2015 to 2018. Additionally, he held the position of Lead Independent Director at Trillium Therapeutics ULC from 2020 to 2021, and was a Non-Executive Director at Algeta ASA from 2013 to 2014. Mr. Pucci has a background in business, having served as the Managing Director at Eli Lilly Sweden AB and as the Senior VP-Global Specialty Medicine Business Unit at Bayer AG from 2001 to 2008. He also held the position of President-US Pharmaceutical Operations at Bayer Pharmaceuticals Corp. and was a Senior Vice President at Bayer Pharma AG. Mr. Pucci completed his undergraduate studies at Università degli Studi di Napoli Federico II and holds an MBA from The University of Chicago Booth School of Business. |
| William F. Feehery |
William F. Feehery is currently the Chief Executive Officer & Director at Certara USA, Inc., Certara, Inc., and Certara Holdings, Inc. He is also an Independent Director at West Pharmaceutical Services, Inc. and a Director at LA-SER Europe Ltd. Additionally, he serves as a Trustee at the Winston Churchill Foundation. Previously, Dr. Feehery held positions such as President & Business Director-Electronics Growth at DuPont Displays, President & Director at MECS, Inc., Director-Global Business at Dupont Photovoltaic Solutions, and President-Industrial Biosciences Business at EIDP, Inc. He was also the President of DuPont Industrial Biosciences USA LLC. Dr. Feehery completed his undergraduate degree at the University of Pennsylvania in 1992. He then went on to earn an MBA and a doctorate from the Massachusetts Institute of Technology in 1995 and 1998, respectively. |
| Robert F. Friel |
Robert F. Friel is currently serving as the Independent Chairman at Xylem, Inc. since 2020. He is also an Independent Director at West Pharmaceutical Services, Inc. since 2020 and a Director at New York Life Insurance Co. since 2019. Additionally, he holds the position of Director at the Analytical Life Science & Diagnostics Association. Previously, Mr. Friel served as the President at PerkinElmer Life & Analytical Sciences, Inc. starting from 2006. In his former roles, Mr. Friel was the President & Chief Executive Officer at Excelitas Technologies Sensors, Inc. He also served as the Chairman & Chief Executive Officer at Revvity, Inc. from 2018 to 2019. Furthermore, he held the position of Chairman-Supervisory Board at EUROIMMUN Medizinische Labordiagnostika AG. Mr. Friel was a Director at Millennium Pharmaceuticals, Inc. from 2005 to 2008 and served as a Director at Fairchild Semiconductor International LLC. He is currently an Independent Director at NuVasive, Inc. from 2016 to 2023. Additionally, he served as an Independent Director at CareFusion Corp. from 2012 to 2015. Mr. Friel started his career at AlliedSignal, Inc. as the Treasurer & Vice President from 1980 to 1999. He also served as a National Trustee at the March of Dimes Foundation. Mr. Friel completed his graduate degree at Fairleigh Dickinson University and his undergraduate degree at Lafayette College. |
| Thomas W. Hofmann |
Thomas W. Hofmann is currently an Independent Director at West Pharmaceutical Services, Inc., a Director at Sunoco Logistics Partners Operations LP, an Independent Director at PVR GP LLC, an Independent Director at Northern Tier Energy LP, a Director at The Fox Chase Cancer Center, a Director at Temple University Health System, Inc., a Director at Young Scholars Charter School, a Director at Sunoco Partners LLC, a Director at The Boys & Girls Clubs of Philadelphia, a Director at The Island School, a Director at Scholar Academies, and a Member-President Leadership Council at the University of Delaware. In the past, he served as a Director at VIASYS Healthcare, Inc., an Independent Director at PVR Partners LP, a Director at Energy Transfer Operating LP, an Independent Director at Northern Tier Energy GP LLC, a Director at Northern Tier Energy LLC, an Independent Director at Columbia Pipeline Partners LP, the Chief Financial Officer & Senior Vice President at ETC Sunoco Holdings LLC, the Chief Financial Officer & Senior Vice President at Braskem America, Inc. (Pennsylvania), and the Chief Financial Officer & Senior Vice President at Sunoco, Inc. (Canada). He received his undergraduate degree from the University of Delaware and his graduate degree from Villanova University. |
| Myla P. Lai-Goldman |
Myla P. Lai-Goldman was the founder of CancerGuide Diagnostics, Inc. (founded in 2009) where she served as the Chief Executive & Scientific Officer from 2009 to 2010. She is also the founder of GeneCentric Therapeutics, Inc. (founded in 2011) where she currently holds the title of Executive Chairman. Additionally, she is the founder of Personalized Science LLC (founded in 2009) and serves as the Managing Partner. Dr. Lai-Goldman's current job(s) include being an Independent Director at West Pharmaceutical Services, Inc. since 2014. She is also a Director at Council for Entrepreneurial Development, Qvella Corp., Akoya Biosciences, Inc., Mercy Bioanalytics, Inc., NovoPath LLC, and Hatteras Venture Partners. In her former positions, Dr. Lai-Goldman served as an Independent Director at Sequenom, Inc. from 2012 to 2016. She was the Medical Director at the Center for Molecular Biology & Pathology from 1991 to 2004. She also held the position of Executive VP, Chief Medical & Scientific Officer at Laboratory Corp. of America Holdings from 1991 to 2008. Additionally, she worked at Roche Biomedical Laboratories, Inc., National Genetics Institute, Inc., and Viro-Med Laboratories, Inc.Dr. Lai-Goldman obtained a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Pennsylvania. |
| Mark A. Buthman |
Mark A. Buthman is currently the Chairman at Pavillon International, an Independent Director at IDEX Corp., an Independent Director at West Pharmaceutical Services, Inc., and the Chief Financial Officer & Director at I-Flow Corp. He previously worked as a Director at Kimberly-Clark de México SAB de CV and Kimberly-Clark Corp., and served as the Executive Vice President at Kimberly-Clark Corp. Mr. Buthman obtained his undergraduate degree from the University of Iowa. |
| Stephen H. Lockhart |
Stephen H. Lockhart is the founder of Sutter Health, which was founded in 1996. He held the title of Chief Medical Officer & Senior Vice President at Sutter Health from 2015 to 2021. Currently, Dr. Lockhart holds the position of Vice Chairman at the National Parks Conservation Association, Chairman at the California State Parks Foundation, Chairman at Parks California, Independent Director at National Research Corp., Independent Director at West Pharmaceutical Services, Inc., Independent Director at Molina Healthcare, Inc., Director at the E. O. Wilson Biodiversity Foundation, Director at NatureBridge, Director at The David & Lucile Packard Foundation, and Secretary & Trustee at the Emergency Care Research Institute. In the past, Dr. Lockhart worked as an Administrative Director-Surgical Services at California Pacific Medical Center, Director at Recreational Equipment, Inc., Director at The Land Trust Alliance, Inc., and Chief Administrative Officer-St. Luke's Campus at California Pacific Medical Center from 2008 to 2010. Dr. Lockhart received a graduate degree from the University of Oxford and a doctorate degree from Cornell University. |
| Molly E. Joseph |
Molly E. Joseph is the founder of Cypress Pass Ventures LLC. She currently holds the position of Chairman at Banmédica SA, Chairman at US Radiology Specialists, Inc, Independent Director at West Pharmaceutical Services, Inc., Independent Director at First Solar, Inc., Director at Young Peoples Chorus of New York City, Director at Young Voices of Austin, Director at Major League Pickleball, Inc., Director at Bend Health, Inc., and Trustee at Santa Clara University. Previously, she served as the Chief Executive Officer at Unitedhealthcare Global from 2005 to 2021, Vice Chairman at Children's HeartLink, Inc., Director at AmSurg Corp., and Executive Vice President-Global at UnitedHealth Group, Inc. from 2009 to 2021. Ms. Joseph obtained her undergraduate degree from Santa Clara University in 1996 and her graduate degree from Georgetown University Law Center in 1999. |
| Deborah L. V. Keller |
Deborah L. V. Keller is currently the Chairman at Wicell Research Institute, Inc., Fishawack Ltd., Avalere Health, Inc., West Pharmaceutical Services, Inc., The Morgridge Institute for Research, Inc., Fishawack Holdco Ltd., Fishawack Health Topco Ltd., Wisconsin Alumni Research Foundation, American Association of Pharmaceutical Scientists, Society of Toxicology, HC Capital LLC, and Black Frame Advisors LLC. She previously held positions as the Executive VP & CEO-Covance Drug Development at Laboratory Corp. of America Holdings, Chief Executive Officer at Labcorp Drug Development, Inc., Director at BioCrossroads, Vice President-Analytical Services at Labcorp Early Development Laboratories Ltd., and Manager-Quality Assurance at Hazleton Laboratories Corp. Ms. Keller has an undergraduate degree and an MBA from the University of Wisconsin, as well as an undergraduate degree from Nazareth College. |
